Tag: IPO
Past Event: 2020 TechGC SPAC Forum
SPACs and Direct Listings have emerged as a significant new liquidity path for high growth tech companies over the last several months. In this three-day virtual forum, we’ll discuss how to approach these liquidity events strategically including evaluating which structure to use, understanding economics / dilution, and how to execute […]
Past Event: Deloitte IPO Bootcamp 2020
Should you IPO? Timing the market can be difficult so it’s important to prepare your company well in advance of your targeted offering date. This exclusive workshop designed for C-suite executives, accounting and finance leaders of pre-IPO companies will offer actionable insights and best practices for a successful IPO. This […]
A Couple of Quick Items Regarding IPO Alternatives
Here are two quick items regarding popular IPO alternatives, SPACs (special purpose acquisition corporations) and primary direct listings: SPACs. In an interview on CNBC with Andrew Ross Sorkin on Thursday, SEC Chair Jay Clayton addressed the recent SPAC frenzy. (Very loosely, SPACs are companies with no real operations formed to […]
Past Event: Cell & Gene Meeting on The Mesa
The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures. This conference covers commercialization hurdles facing the cell and gene therapy sector as well as a wide range of topics […]
Past Event: Bay Area IPO Readiness Workshop
Cooley partner Dave Peinsipp, Deloitte and leaders from other organizations well-versed in the IPO, direct listing and SPAC processes shared their insights on the next normal. Topics include Current market conditions Regulatory considerations How to prepare for the IPO process Life as a public company Actionable insights from a CFO/controller […]
Past Event: The 2020 IPO Comeback Series
After IPO issuances came to a near-halt in late Q1 and early Q2 2020, the window reopened wide this summer when much-needed liquidity infused the markets and led to one of the strongest months for IPOs in 13 years. This two-part executive webinar series was on the novel challenges of […]
London Listings for People’s Republic of China (PRC) Companies
The United Kingdom (UK) offers a range of markets that companies in the People’s Republic of China (PRC) might consider as venues for a primary or secondary listing of their equity securities. This blog post provides a high-level overview of the types of equity securities which might be listed, factors […]
25 Considerations in Preparing for an IPO in the UK
1. Selecting a stock exchange or market Understand the benefits of the alternative listing options, such as the premium or standard segments of the Main Market or the AIM market of the London Stock Exchange, which are the main options for a company considering an IPO in the UK. Analyse […]
10 Key Considerations for IPOs During COVID-19
Despite the COVID-19 pandemic and associated stock market difficulties, some IPOs are getting done. Prior to the pandemic, IPO timelines for the rest of 2020 were largely focused on navigating around the upcoming U.S. elections. The focus has now shifted to the duration and impact of the pandemic, and when […]
25 Considerations in Preparing For an IPO: Tech Companies
1. Experienced advisers Choose experienced advisers, including lawyers, auditors and financial consultants (if necessary), and get them involved early. Advisers who are up to date on the latest investor and regulator concerns and work routinely with the SEC and investment bankers – and each other – will help proactively identify […]